Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin.
The administration of intravesical bacille Calmette-Guérin (BCG) in early stages of bladder cancer is usually a safe therapy. Side-effects of BCG immunotherapy can be of both local and systemic nature. We report the first case of Henoch-Schönlein purpura following intravesical administration of BCG.
Nan
Daniel N
DN
Department of Internal Medicine, University Hospital Marqués de Valdecilla, ES-39008 Santander, Spain.
Fernández-Ayala
Marta
M
García-Ibarbia
Carmen
C
Gutiérrez-Santiago
Mar
M
Hernández
José L
JL
D000283:Administration, Intravesical; D000368:Aged; D006801:Humans; D011695:IgA Vasculitis / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009163:Mycobacterium bovis / Q000472:pathogenicity*; D001749:Urinary Bladder Neoplasms / Q000628:therapy